樂天醫藥 - Rakuten Medical

Rakuten Medical Logo

Careers

職涯與工作機會

JOIN THE RAKUTEN MEDICAL TEAM!

Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives. Headquartered in the United States, Rakuten Medical has 6 locations in 5 countries, Japan, the Netherlands, Germany and Taiwan.

 

We follow the science, work for the patients, and hunt for innovation. Our culture embodies collaboration, transparency, and hard-work. We are building a company unlike any other biotechnology entity. Join us!

OUR BENEFITS

  • Excellent health, vision and dental plans
  • Life insurance
  • Flexible Paid Time Off
  • Competitive benefits and compensation
  • Stock options
  • 401k

CAREER OPPORTUNITIES

We are Rakuten Medical, Inc., a privately funded, clinical stage, global Biopharmaceutical Company with locations in San Mateo, CA (Corporate Headquarters) and San Diego, CA (R&D Science Park), and regional offices in Japan, Taiwan, The Netherlands, and Germany.

 

Our mission is to offer new, safe, and effective cancer treatment options that could transform and improve the lives of patients. Rakuten Medical was created out of passion, ambition, and the motivating strength to take on the battle against a disease that affects millions across the world – cancer. Rakuten Medical embraces a culture of compassion. We abide by our promise to develop effective, safe and innovative therapies for patients as soon as scientifically possible, without delay, to extend and improve cancer treatment worldwide. Our slogan is “CONQUERING Cancer. For LIFE”.

 

We are supported by investors that have the commitment to build a fully integrated R&D and commercial biopharmaceutical company to innovate, develop, and commercialize cutting edge cancer therapies.

 

Currently we are developing therapies based on a novel proprietary technology platform that utilizes antibodies conjugated with payloads that are specifically activated at the tumor site. Our first clinical product is in Phase 3 pivotal clinical testing to treat terminal cancer patients. This is a first-in-class product with unique pharmacological activity and with the potential to have a broad impact in cancer. Given the rapid progression of the clinical studies we are quickly growing our teams to build and enhance in-house expertise with the intent to expand our R&D operations, clinical programs and prepare for the commercialization of our products.

People
×
Innovation
×
Action
×
A Note from Our Chairman

In 2012, my father was diagnosed with pancreatic cancer. I was ready to do anything for him to be cured. With that sole purpose, I read many scientific papers from all over the world, and I met and talked with numerous experts in the field. How could I cure my father’s cancer? I searched every single possibility available.

That is when I found out about photoimmunotherapy that was only at an early stage of research. Although I had many doubts about this completely new approach, desperate for a miracle, I immediately went to meet the researcher.

Everyone was still doubtful at that stage. But the more I heard about this research, the more it made sense. 

I instinctively thought, “This is it.” It was the same feeling I got as when I grasped that the internet would change the world forever. Somehow, wishing to save my father, I immediately made up my mind to support the research personally to speed it up.

Unfortunately, we didn’t make it in time to save my father. But I decided to continue my support. My father who was as an economist always said, “One important mission of corporations is to contribute to humanity.”

Left behind, I resolved to provide this latest treatment to as many people as possible. It will surely be a path fraught with difficulties. But right at this moment there are many who are suffering from cancer, many who wish to save the lives of their loved ones, and I know exactly how they feel.

To provide this treatment as soon as possible, to bring this treatment to as many people as possible, I will not fail to support this research from now on.

Chairman, Rakuten Medical, Inc.

Hiroshi Mikitani

×